By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global ...

The NHS is to trial “robo minders” to keep an eye on dementia patients in their own homes. The technology will allow hospital ...

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

Clinical trials are notorious for being expensive and slow, with rising costs and declining efficiency. According to Bernstein, industry R&D spending grew 44% between 2012 and 2022, while the number ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

Vascular toxicity associated with cancer therapies is a leading cause of cardiovascular adverse events in patients with ...

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

Two men turned Burghley Horse Trials into their own stunt arena, their reckless riding highlighting the growing problem of ...

The reporting methods of noninferiority randomized clinical trials are often inconsistent, with many publications omitting ...

H LUNDBECK A/S (($HLUYY)) announced an update on their ongoing clinical study. H. Lundbeck A/S is currently conducting a clinical trial titled ...